Originally published on TVBS | Reporter: Xu Zhi-Jia

Taipei Medical University showcased its AI Multimodal Imaging Precision Health Platform at the Taiwan Healthcare Expo. (Photo courtesy of the hospital.)

The Taiwan Healthcare Expo kicked off today (1st) and will run for four days at Taipei Nangang Exhibition Center, Hall 1. Taipei Medical University Hospital is unveiling an advanced lineup of medical robotics, including Taiwan’s first minimally invasive surgical robot system approved by the U.S. FDA and the country’s first robotic rehabilitation center equipped with high-, mid-, and low-level rehabilitation robots.
Additionally, the hospital is presenting the AI Multimodal Imaging Precision Health Platform, which can predict four diseases from a single CT scan, as well as an intelligent infusion pump system capable of fully automating drip rate adjustments and real-time monitoring.

Taipei Medical University (TMU) has established Taiwan’s first diverse robotic rehabilitation center, equipped with high-, mid-, and low-level rehabilitation robots. (Photo courtesy of the hospital.)

TMU Hospital Director Jeng-Fong Chiou stated that over the past three years, the COVID-19 pandemic has transformed daily life, leading to the emergence of various “zero-contact, automated” preventive measures. In particular, AI and robotics have made significant strides in the medical industry.

In recent years, TMU Hospital has actively promoted the development of a smart hospital, introducing Taiwan-made cutting-edge robotic surgical navigation systems and establishing the country’s first robotic rehabilitation center with multi-level rehabilitation robots. Additionally, the hospital has implemented advanced smart infusion pumps, showcasing its strong capabilities in medical innovation.

In addition, the Deep-Lung AI Multimodal Imaging Precision Health Platform, developed in collaboration, is now officially online, bringing AI-driven big data in healthcare from theory into real-world medical practice.

Taipei Medical University Vice President and Principal Investigator Cheng-Yu Chen  stated that the Deep-Lung AI Multimodal Imaging Precision Health Platform is a comprehensive AI-assisted radiology system for early screening of thoracic diseases. Using a single 3D low-dose chest CT (LDCT) scan, the AI algorithm analyzes the heart, lungs, and bones, providing early detection for four diseases: lung cancer, emphysema, coronary artery calcification, and osteoporosis. This is a globally pioneering service.

Cheng-Yu Chen  further noted that as Taiwan’s aging population accelerates, the government is expected to gradually introduce subsidies for screening programs, including LDCT scans. However, this will significantly increase the workload for radiologic technologists and diagnostic radiologists. Moreover, patients undergoing multiple CT scans for different body parts face the risk of excessive radiation exposure.

With AI assistance, the time required for analyzing CT scan images can be reduced from 15 minutes to just 2 minutes. Additionally, since only a single LDCT scan is needed, patients’ radiation exposure is significantly minimized.

Kinguide Robotic-Assisted Surgical System aids surgeons in performing precise spinal surgeries. (Image provided by the hospital.)

The Kinguide Agile Hybrid Navigation System is a high-precision navigation platform that supports preoperative planning and image-guided procedures. It has received market approval from Taiwan’s Ministry of Health and Welfare’s Food and Drug Administration (TFDA). By integrating advanced imaging equipment within hybrid operating rooms, the system captures real-time intraoperative images, reconstructs 3D imaging models, and assists surgeons in planning, simulating, and executing minimally invasive spinal surgeries. This approach significantly reduces blood loss and accelerates recovery, achieving the goal of minimally invasive precision surgery.

Additionally, the COVID-19 pandemic has driven the development of contact-free medical solutions, including advancements in IV (intravenous) therapy, a common treatment for hospitalized patients. To enhance safety and accuracy in infusion therapy, Taipei Medical University Hospital has adopted the Inventec Smart Infusion System, conducting clinical field validation and co-developing optimized integration processes.

By utilizing computer-linked verification, the system ensures precise patient identification, nurse authentication, and injection site confirmation. It enables precise control over infusion rates, remote monitoring, and real-time adjustments. Additionally, it synchronizes medical orders, drug information, patient data, and pharmacopoeia references, significantly enhancing infusion safety.